NuVasive excelling on strength of new leadership — 4 analyst insights

Spinal Tech

NuVasive has made significant inroads with its main product portfolio since it appointed new senior leadership, Seeking Alpha reports.

What you should know:

1. NuVasive has improved on its core X360 platform as well as its Pulse robotics platform.

2. Since June, the company's shares have increased some 35 percent.

3. Seeking Alpha's analyst was bullish on NuVasive's near-to-medium-term future because of the advances behind the company's two platforms.

4. The analyst is optimistic about 2020 and 2021 and the company's long term future, increasing his performance expectations through 2028.

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers